BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
BMY.RT
Delisted
BMY.RT was delisted on the 31st of December, 2020.
580 hedge funds and large institutions have $1.89B invested in Bristol-Myers Squibb Company Contingent Value Rights in 2020 Q2 according to their latest regulatory filings, with 67 funds opening new positions, 91 increasing their positions, 213 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
580
Holders Change
+2
Holders Change %
+0.35%
% of All Funds
11.92%
Holding in Top 10
11
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-8.33%
% of All Funds
0.23%
New
67
Increased
91
Reduced
213
Closed
61
Calls
$24.4M
Puts
$1.24M
Net Calls
+$23.1M
Net Calls Change
-$2.58M
Top Buyers
Top Sellers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$35.6M |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$3.29M |
| 3 |
JG
3
Jefferies Group
New York
|
$0 |
| 4 |
HM
4
HealthCor Management
New York
|
$3.99M |
| 5 |
5
Renaissance Technologies
New York
|
$21.7M |
